
Pediatric Oncologist

No OPD information available
Febrile Neutropenia
Acute Lymphoblastic Leukemia (ALL)
Agranulocytosis
Angiosarcoma
Bone Marrow Aspiration
Embryonal Tumor with Multilayered Rosettes
Ganglioneuroblastoma
Gliomatosis Cerebri
Hepatic Hemangioma
Hypercalcemia
Infantile Neutropenia
Kienbock's Disease
Leukemia
Milk-Alkali Syndrome
Neuroblastoma
Neuroepithelioma
Osteonecrosis
Bhavna D. Padhye is a female medical professional who helps patients with different health issues. She is skilled in treating conditions like febrile neutropenia, acute lymphoblastic leukemia (ALL), agranulocytosis, and more. Bhavna uses her expertise to perform procedures such as bone marrow aspiration and provides care for diseases like neuroblastoma and osteonecrosis.
Patients trust Bhavna because she communicates well with them, explaining things clearly and listening to their concerns. She stays updated with the latest medical knowledge and research to provide the best care possible. Bhavna works closely with other medical professionals, collaborating on treatment plans and sharing information to ensure the best outcomes for patients.
Bhavna's work has positively impacted many patients' lives by providing effective treatments and compassionate care. Her dedication to improving patient outcomes is evident in her participation in clinical trials and research studies. One of her notable publications discusses the importance of sharing genetic data with research participants in pediatric cancer trials.
In a current clinical trial, Bhavna is involved in treating children with hepatoblastoma using a medication called temsirolimus. This trial aims to improve treatment outcomes for children with this type of cancer.
Overall, Bhavna D. Padhye is a dedicated and knowledgeable medical professional who uses her skills and expertise to help patients facing challenging health conditions. Through her commitment to ongoing learning and collaboration with colleagues, she continues to make a positive impact on the lives of her patients.
Enrollment Status: Active not recruiting
Published: April 10, 2025
Intervention Type: Drug, Other, Procedure
Study Drug:
Study Phase: Phase 3
